News

CDI’s commercial iCell Neurons were used by GlaxoSmithKline (GSK) researchers to model neuronal loss in human AD brains by exposing them to beta-amyloid 1-42 (AB1-42), which grows in

This divestment is part of Tessenderlo’s focus on specialty products and services in the areas of food, agriculture, water management and valorizing bio-residuals. Tessenderlo had announced its plan

During the 12 week trial that included 83 term infants, 58 were formula-fed while the rest were breast-fed. The formula fed infants were either assigned to a control

Having met FDA’s requirement, the company has now gained an additional 6 months US market exclusivity for Aciphex, which will expire on 8 November 2013. The granting of

Fast-acting APL-130277 is a thin film sublingual formulation of apomorphine, which is designed for use in the rescue of Parkinson’s patients from "off" episodes in which the patients

IPR is involved in upgrading and manufacturing control and automation products, inspection systems for pharmaceutical equipment such as tablet presses. Bosch Packaging Services general manager Gary Anderton said

The FDA approved long-acting anticholinergic was indicated for the maintenance treatment of bronchospasm coupled with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. When administered two times

XEN402 is designed to treat pain by targeting sodium channels located at sensory nerve endings. Teva Pharmaceutical Industries president and CEO Dr. Jeremy Levin said, "XEN402 fits this

Theravance leveraged its multivalent approach of drug design to discover the investigational inhaled long-acting muscarinic antagonist TD-4208. Theravance research and early clinical development senior vice president Mathai Mammen